Target intelligence / Profile preview

ribosomal protein L7a pseudogene 9 (RPL7AP9)

Target
RPL7AP9
Molecular classification
Other (Processed pseudogene, non-coding genomic locus)
01

Overview

ribosomal protein L7a pseudogene 9 (RPL7AP9) is a non-functional, processed pseudogene related to the ribosomal protein L7a gene. Pseudogenes like RPL7AP9 are DNA sequences that arise from duplication or retrotransposition of genes, but accumulate mutations and typically do not encode functional proteins. While the canonical RPL7A gene is a structural constituent of the ribosome and is essential for protein synthesis[1][3], its pseudogenes—including RPL7AP9—are not involved in ribosomal function or known cellular pathways and hold no direct therapeutic significance. "RPL7AP9" is often listed with commercial reagents for gene knockdown, but the knockdown of this pseudogene would not affect ribosomal function, as it is not translated[4][6]. Disease roles, interacting drugs, and mechanisms cited for "RPL7A" do not apply to "RPL7AP9"[3]. The presence of multiple pseudogenes for ribosomal protein genes in the genome is a common feature, but only the functional gene (RPL7A) is of biological and therapeutic interest[1][3]. In summary, RPL7AP9 is not a valid therapeutic target; it is a processed pseudogene, not a functional receptor, enzyme, or transporter.

Other names
RPL7AP59RPL7A_24_1258rpL7aribosomal protein L7a pseudogene 59RPL7AP9

Beyond the preview

Go deeper on ribosomal protein L7a pseudogene 9 (RPL7AP9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ribosomal protein L7a pseudogene 9 (RPL7AP9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call